脂解激活脂蛋白受體(LSR)單克隆抗體
Monoclonal Antibody to Lipolysis Stimulated Lipoprotein Receptor (LSR)
LISCH7; ILDR3; LISCH; Lipolysis-Stimulated Remnant; Immunoglobulin-Like Domain Containing Receptor 3
- 編號UMAD744Hu21
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源單抗制備
- 宿主小鼠
- 效價(jià)(克隆號)C2
- Ig亞型 IgG1 Kappa
- 純化方式蛋白A + 蛋白G親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPD744Hu01-脂解激活脂蛋白受體(LSR)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度1mg/ml
- 且適物種Rattus norvegicus (Rat，大鼠)
- 應(yīng)用WB; IHC
如果抗體需用于流式細(xì)胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價(jià)格 ¥ 333 ¥ 777 ¥ 1110 ¥ 2775 ¥ 11100
- 欲了解實(shí)際交易價(jià)格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Sample: Human Cardiac Muscle Tissue; Primary Ab: 30μg/ml Mouse Anti-Human LSR Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody (Catalog: SAA544Mu19)
-
DAB staining on IHC-P;
Sample: Human Skeletal muscle Tissue;
Primary Ab: 30μg/ml Mouse Anti-Human LSR Antibody
Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
DAB staining on IHC-P;
Sample: Human Cardiac Muscle Tissue
Primary Ab: 30μg/ml Mouse Anti-Human LSR Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19) -
DAB staining on IHC-P;
Sample: Human Skeletal muscle Tissue
Primary Ab: 30μg/ml Mouse Anti-Human LSR Antibody
Control: Used PBS instead of primary antibody
Second Ab: 2μg/ml HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
Figure. Western Blot; Sample: Recombinant LSR, Human.
-
Western Blot; Sample: Lane1: Rat Liver lysate; Lane2: 293T cell lysate
Primary Ab: 2μg/ml Mouse Anti-Human LSR Antibody
Second Ab: 0.2μg/mL HRP-Linked Caprine Anti-Mouse IgG Polyclonal Antibody
(Catalog: SAA544Mu19)
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
特異性
該抗體是針對LSR的小鼠單克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識別LSR。
用法
Western blotting: 0.01-2μg/mL;
Immunohistochemistry: 5-30μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定，具體方法如下：在37°C孵育48小時(shí)，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
抗體標(biāo)記定制服務(wù)
Protein-A/G純化柱
細(xì)胞和組織染色液
抗體陽性對照品
組織/切片定制服務(wù)
磷酸化抗體定制服務(wù)
免疫印跡(WB)實(shí)驗(yàn)服務(wù)
免疫組織化學(xué)(IHC)實(shí)驗(yàn)服務(wù)
免疫細(xì)胞化學(xué)(ICC)實(shí)驗(yàn)服務(wù)
流式細(xì)胞術(shù)(FCM)實(shí)驗(yàn)服務(wù)
免疫沉淀(IP)實(shí)驗(yàn)服務(wù)
免疫熒光(IF)實(shí)驗(yàn)服務(wù)
緩沖液
DAB顯色試劑盒
SABC試劑盒
長臂生物素標(biāo)記試劑盒
實(shí)時(shí)熒光定量PCR實(shí)驗(yàn)服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPD744Hu01 | 脂解激活脂蛋白受體(LSR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPD744Hu02 | 脂解激活脂蛋白受體(LSR)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAD744Hu01 | 脂解激活脂蛋白受體(LSR)多克隆抗體 | WB; IHC |
| ULAD744Hu71 | 脂解激活脂蛋白受體(LSR)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| ULAD744Hu81 | 脂解激活脂蛋白受體(LSR)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| UMAD744Hu21 | 脂解激活脂蛋白受體(LSR)單克隆抗體 | WB; IHC |
| UMAD744Hu27 | 脂解激活脂蛋白受體(LSR)單克隆抗體 | ICC/IF |
| UMAD744Hu23 | 脂解激活脂蛋白受體(LSR)單克隆抗體 | WB; IHC; ICC; IP. |
| UMAD744Hu24 | 脂解激活脂蛋白受體(LSR)單克隆抗體 | IHC |
| UMAD744Hu25 | 脂解激活脂蛋白受體(LSR)單克隆抗體 | Testing in progress |
| UMAD744Hu29 | 脂解激活脂蛋白受體(LSR)單克隆抗體 | WB; IHC; ICC; IP. |
| UMAD744Hu22 | 脂解激活脂蛋白受體(LSR)單克隆抗體 | WB; IHC |
| ULAD744Hu72 | 脂解激活脂蛋白受體(LSR)單克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| USED744Hu | 脂解激活脂蛋白受體(LSR)檢測試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| ULMD744Hu | 脂解激活脂蛋白受體(LSR)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
| UPSD744Hu01 | 脂解激活脂蛋白受體(LSR)抗體對 | ELISA; CLIA; ELISPOT; Luminex; Immunochromatography and other Immunoassays. |
| UKSD744Hu01 | 脂解激活脂蛋白受體(LSR)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗(yàn)法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| American Association for Cancer Research | LSR antibody therapy inhibits ovarian epithelial tumor growth by inhibiting lipid uptake [pubmed:29187404] |
